February 24, 2025 - 02:10

As the excitement builds for the upcoming 2025 Ambetter Health 400 at Atlanta Motor Speedway, fantasy racing enthusiasts are gearing up to finalize their lineups. Expert Mike McClure has analyzed the field and is ready to share his top picks for this thrilling NASCAR event.
With a mix of seasoned veterans and rising stars, the race promises to deliver intense competition. Key drivers to watch include those with a strong track record at Atlanta, as well as those who have shown impressive performance in recent races. McClure emphasizes the importance of considering both current form and historical data when selecting drivers.
Additionally, pay attention to the weather conditions and how they might impact the race strategy. Teams may make adjustments to their setups based on forecasted conditions, which could play a significant role in the outcome. With careful planning and strategic choices, fantasy players can maximize their chances of success in this high-stakes event.
 
                November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
 
                October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
 
                October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
 
                October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...